Effects of acetazolamide combined with remote ischemic preconditioning on risk of acute mountain sickness: a randomized clinical trial - Liu, Moqi; Jiao, Xueqiao; Li, Rui; Li, Jialu; Wang, Lu; Wang, Liyan; Wang, Yishu; Lv, Chunmei; Huang, Dan; Wei, Ran; Wang, Liming; Ji, Xunming; et al. (BMC medicine, 2024)
Keywords: Acetazolamide; Acidosis; Acute Disease; Acute mountain sickness; Alleles; Altitude; Altitude sickness; Altitude Sickness - diagnosis; Altitude Sickness - prevention & control; Analysis; Antibodies; Blood pressure; Cardiovascular disease; Care and treatment; Clinical trials; Diagnosis; Dosage and administration; Drug dosages; Exposure; Gene polymorphism; Genetic analysis; Genetic aspects; Genetic polymorphisms; Heart rate; High altitude; Humans; Hypoxia; Hypoxia - prevention & control; Illnesses; Inflammation; Intervention; Ischemia; Ischemic Preconditioning; Metabolic acidosis; Mountain sickness; Mountains; Oxygen content; Oxygen saturation; Pathogenesis; PDGF; Physiology, Pathological; Platelet-derived growth factor; Preconditioning; Prevention; Prospective Studies; Pulmonary arteries; Remote ischemic preconditioning; China; Beijing China; Acetazolamide; Acute mountain sickness; Remote ischemic preconditioning; PDGF